The wonders of EndoSure: A breakthrough in endometriosis diagnosis

Endometriosis is a complex condition that affects millions of women worldwide, yet diagnosis often takes years. Many patients endure chronic pain, fertility challenges, and emotional distress before receiving answers. Traditionally, confirmation of endometriosis required invasive surgery, such as laparoscopy. However, a new diagnostic tool called EndoSure is helping to change that.

EndoSure is a non-invasive test designed to detect the presence of endometriosis by measuring the electrical activity of the bowel and pelvic area. Developed by Dr. Mark Noar in the United States, this test uses a process known as electroviscerography (EVG). During the procedure, small sensors are placed on the abdomen and chest to record the natural electrical signals of the intestines. Because endometriosis can cause inflammation and hormonal changes that alter these signals, the test can identify patterns associated with the condition.

The procedure is quick—taking around 40 minutes—and does not require anaesthesia or specialist interpretation. Early research suggests impressive accuracy, with sensitivity and specificity rates reportedly above 90 percent. Although more studies are needed to confirm these results on a larger scale, the findings so far are very encouraging.

The introduction of EndoSure in the UK offers hope to thousands of women who face long diagnostic delays. By providing an accessible, low-risk alternative to surgery, this technology could shorten the average eight-year wait for a diagnosis and allow earlier treatment or lifestyle management.

Ultimately, EndoSure represents an exciting leap forward in women’s health. It combines science, innovation, and compassion to deliver faster answers and better outcomes for patients—bringing us one step closer to transforming how endometriosis is recognised and treated. Mr Morris now offers the EndoSure test in his London clinics.